Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of diseases through administration of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide

Treatment of diseases through administration of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide

US Patent 9649306 · Granted May 16, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

4-carboxamido-isoindolinone derivatives as selective PARP-1 inhibitors2023
4-carboxamido-isoindolinone derivatives as selective parp-1 inhibitors2022
Synthesis of cerdulatinib2022
Methods of producing molindone and its salts2021
Safety valve2021
Synthesis of cerdulatinib2020
4-carboxamido-isoindolinone derivatives as selective PARP-1 inhibitors2020
Methods of producing molindone and its salts2020
Asymmetric process for the preparation of thieno-indoles derivatives2020
4-carboxamido-isoindolinone derivatives as selective PARP-1 inhibitors2019
Thieno[2,3-e]indole derivatives as new antitumor agents2019
Asymmetric process for the preparation of thieno-indoles derivatives2019